The role of gene TREM-1 at children who have operation congenital heart diseases
https://doi.org/10.18705/2311-4495-2019-6-4-5-12
Abstract
Introduction. Congenital heart disease (CHD) is one of the most common fetal malformations resulting in high postnatal disability and mortality. Despite significant advances in the diagnosis and surgical correction of defects, the molecular genetic aspects of the pathogenesis of this disease are still not fully understood. TREM-1 key receptor for the innate immune response, inflammatory inducing and involved in the pathogenesis of acute and chronic diseases.
Purpose. To determine genotype frequencies of the TREM-1 gene in children with congenital heart disease.
Methods. 154 children with congenital heart disease were included in the study. Genomic DNA isolated from peripheral blood leukocytes was used as a material for the study. The genotyped were with RT-PCR by 8 loci (rs1817537, rs3804277, rs6910730, rs7768162, rs2234246, rs4711668, rs9471535, rs2234237).
Results and conclusions. The C/C genotype of the rs2234246 polymorphism was more frequently found in the group of patients with ductus-independent CHD compared with the ductus-dependent CHD (38.2 % vs. 15.4 %, p = 0,006). The T/T genotype of the rs4711668 was more frequently detected in the ductus-independent CHD (24 % vs. 8 % p = 0.02).
The study did not establish differences in the distribution of alleles and genotypes of the TREM-1 gene in patients with CHD and healthy children. At the same time, statistically significant differences in the distribution of genotypes of polymorphic rs2234246 and rs4711668 variants in groups of patients with ductus-dependent and ductus-independent blood circulation were obtained.
About the Authors
A. V. TsepokinaRussian Federation
Tsepokina Anna V. - Junior Researcher, Laboratory of Genomic Medicine, NII KPSSZ.
Sosnoviy blvd., 6, Kemerovo, 650002
Competing Interests: not
M. V. Khutornaya
Russian Federation
Khutornaya Mariya V. - Junior Researcher, Laboratory of Genomic Medicine, NII KPSSZ.
Kemerovo
Competing Interests: not
A. V. Shabaldin
Russian Federation
Shabaldin Andrej V. - Dr. Sc., Leading Researcher, Cell Technology Laboratory, NII KPSSZ.
Kemerovo
Competing Interests: not
A. V. Ponasenko
Russian Federation
Ponasenko Anastasiya V. - PhD, Head of the Genomic Medicine Laboratory, NII KPSSZ.
Kemerovo
Competing Interests: not
References
1. Saperova EV, Vahlova IV. Congenital heart diseases in children: incidence, risk factors, mortality. Voprosy sovremennoj pediatrii=Current Pediatrics. 2017;16(2):126-133. In Russian
2. Nasonov EL, Popkova TV. Role of interleukin 1 in the development of atherosclerosis. Nauchno-prakticheskaya revmatologiya=Rheumatology Science and Practice. 2018;56:28-34. In Russian
3. Siniczkij MY, Ponasenko AV. The role of polymorphism and expression features of innate immune response receptors genes in the pathogenesis of infectious endocarditis. Rossijskij kardiologicheskij zhurnal=Russian Journal of Cardiology. 2018;10:145-150. In Russian
4. Caillon A, Paradis P, Schiffrin EL. Role of immune cells in hypertension. Br J Pharmacol. 2019;176(12):1818-1828.
5. Xu M, Liu PP, Li H. Innate immune signaling and its role in metabolic and cardiovascular diseases. Physiol Rev. 2019;99(1): 893-948.
6. Kuchkova OG, Golomidov AV, Velikanova EA et al. CRP and TREM-1 as early markers of noninfectious systemic inflammatory response in preterm neonates. Medicina v Kuzbasse=Medicine in Kuzbass. 2016;15(3):27-33. In Russian
7. Kouassi KT, Gunasekar P, Agrawal DK et al. TREM-1; is it a pivotal target for cardiovascular diseases? J Cardiovasc Dev Dis. 2018;5(3). pii:E45.
8. Kutikhin AG, Ponasenko AV, Khutornaya MV et al. Association of TLR and TREM-1 gene polymorphisms with atherosclerosis severity in a Russian population. Meta Gene. 2016;9:76-89.
9. Ponasenko AV, Kutikhin AG, Khutornaya MV et al. Association of TREM-1 gene polymorphisms with infective endocarditis. Infekciya i immunitet=Russian Journal of Infection and Immunity. 2015;5(4):331-338. In Russian
10. Boufenzer A, Lemarie J, Simon T et al. TREM-1 mediates inflammatory injury and cardiac remodeling following myocardial infarction. Circ Res. 2015;116(11):1772-1782.
11. Velez DR, Fortunato SJ, Thorsen P et al. Preterm birth in Caucasians is associated with coagulation and inflammation pathway gene variants. PLoS One. 2008;3(9):e3283.
12. Replogle JM, Chan G, White CC et al. A TREM1 variant alters the accumulation of Alzheimer-related amyloid pathology. Ann Neurol. 2015;77(3):469-477.
13. Peng LS, Li J, Zhou GS et al. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and septic shock in a Chinese Han population. World J Emerg Med. 2015;6(2):123-130.
14. Khutornaya MV, Ponasenko AV, Radivilko AS et al. Impact of innate immunity genes in development of critical postoperative complications after coronary artery bypasses grafting. Translyacionnaya medicina=Translational Medicine. 2017;4(5):15-27. In Russian
15. Jeremie L, Amir B, Marc D et al. The triggering receptor expressed on myeloid cells-1: a new player during acute myocardial infarction. Pharmacol Res. 2015;100:261-265.
16. AldasoroArguinanoAA, Dade S, Stathopoulou M et al. TREM-1 SNP rs2234246 regulates TREM-1 protein and mRNA levels and is associated with plasma levels of L-selectin PLoS One. 2017;12(8):e0182226.
Review
For citations:
Tsepokina A.V., Khutornaya M.V., Shabaldin A.V., Ponasenko A.V. The role of gene TREM-1 at children who have operation congenital heart diseases. Translational Medicine. 2019;6(4):5-12. (In Russ.) https://doi.org/10.18705/2311-4495-2019-6-4-5-12